Options Unveils H1 2026 AtlasFeed and Raw Market Data Feed Expansion August 11, 2026 Options Technology (Options), the leading managed IT services and technology solutions provider, today announced the immediate availability of expanded market data feeds following a record-breaking first half of 2026. This launch delivers enhanced connectivity for U.S. options and equities as well as Middle Eastern markets, supporting clients with expanded normalized and native feed coverage from [...]
Rehlko Expands Power Plus™ Connected-Services Capabilities, Enhancing Value Across Installed Base August 11, 2026 Rehlko Power Plus™ Delivers 24/7 Remote Monitoring, Advanced Diagnostics, and Fleet-Wide Asset Visibility to Critical Power Systems
FGE NexantECA Acquires Square Commodities, Accelerating Its Green Molecules Strategy August 11, 2026 Combined business will deliver the most complete supply and demand picture across renewable fuels, through FGE NexantECA's AI-native platform, Lumen.
ILiAD Biotechnologies Expands Board of Directors and Appoints Chief Business Officer August 11, 2026 Suha Jhaveri, Bill Warren and Jim Wassil added to ILiAD Board of Directors; Antony Blanc appointed Chief Business Officer Appointments deepen vaccine development expertise and enhance global commercial and strategic leadership
Smarsh Named to Inc. 5000 for the 19th Consecutive Year August 11, 2026 Smarsh continues to lead the industry with sustained AI-driven innovation and growth
GXP-Storage Expands UK Capacity with Third Restricted-Access Facility at Raunds, Northamptonshire August 11, 2026 The company’s third UK facility adds 95,000+ cubic feet of GxP-compliant, environmentally controlled storage capacity and serves as a consolidation point for regulated materials across the UK, EMEA, and beyond.
Alfasigma to Acquire Nordic Group B.V. Expanding Its Specialty Care Portfolio and Presence in Europe August 11, 2026 Transaction highlights Advances Alfasigma’s M&A-led global growth strategy, purposely focused on immunology and gastroenterology. Synergy with Alfasigma’s specialty rheumatology portfolio, adding Nordic Pharma’s rheumatoid arthritis business, including the Nordimet® franchise. Expands footprint by adding Canada and Japan; strengthens presence in Europe, with direct operations in 18 countries, with 265 employees. Adds approximately €190 million in 2025 revenue. Financial terms of the transaction are not disclosed.
Naser Taher Named Among Forbes Middle East’s Top 100 CEOs 2026 August 11, 2026 Recognition highlights the MultiBank Group Founder and Chairman’s leadership, global experience and contribution to the financial services industry
Silence Therapeutics Announces Proposed Public Offering of $150 Million of American Depositary Shares August 10, 2026 Silence Therapeutics plc (“Silence” or the “Company”), a global clinical-stage biotechnology company developing novel short interfering RNA (“siRNA”) therapies, today announced that it has commenced an underwritten public offering of approximately $150 million of its American Depositary Shares (“ADSs”), each representing three ordinary shares of £0.05 each in the capital of the Company, in the [...]
Point2 Completes $136M Series B Funding with Arm, LB Investment, and Maverick Silicon August 10, 2026 New Funding Further Solidifies Point2’s e‑Tube Technology Platform as the Foundation for Next-Generation AI Data-Center Interconnect